U-Ploid Biotechnologies

U-Ploid Biotechnologies is an early-stage biotechnology company developing first-in-class therapeutics to address age-related decline in egg quality.

Its lead programme targets chromosomal instability in human oocytes which is a primary driver of IVF failure, miscarriage, and congenital disorders in women of advanced maternal age.

Treatments are designed to integrate into existing assisted reproduction procedures.

U-Ploid is based at the Bioescalator incubator on Oxford University's Old Road Campus.